PVI
HAE icon

Pura Vida Investments’s Haemonetics HAE Stock Holding History

Pura Vida Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-70,000
Closed -$4.94M – 270
2021
Q3 		$4.94M Buy
+70,000
New +$4.42M 0.15% 147

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Pura Vida Investments's HAE Position: Q4 2021 in Review

Pura Vida Investments sold out of Haemonetics (HAE) in Q4 2021, closing a stake of 130,000 shares — an estimated $9.18M sold.

Pura Vida Investments first reported a position in HAE in Q3 2020 and held it in 3 quarters. The position peaked at $9.8M in Q4 2020. 257 funds tracked by Wall St. Rank hold HAE as of Q4 2021.

  • Pura Vida Investments reported no remaining Haemonetics position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 130,000 Haemonetics shares in Q4 2021, an estimated $9.18M.
  • Pura Vida Investments first reported a position in Haemonetics in Q3 2020 and held it in 3 quarters.
  • Pura Vida Investments's Haemonetics position peaked at $9.8M in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Haemonetics as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.